Thomas C Hanff
Overview
Explore the profile of Thomas C Hanff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
824
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sideris K, Lazar-Molnar E, Kyriakopoulos C, Taleb I, Hurst D, Ugolini S, et al.
Clin Transplant
. 2024 May;
38(5):e15330.
PMID: 38716787
Introduction: Since the 2018 change in the US adult heart allocation policy, more patients are bridged-to-transplant on temporary mechanical circulatory support (tMCS). Previous studies indicate that durable left ventricular assist...
12.
Visker J, Brintz B, Kyriakopoulos C, Hillas Y, Taleb I, Badolia R, et al.
bioRxiv
. 2024 Apr;
PMID: 38659908
Mechanical unloading and circulatory support with left ventricular assist devices (LVADs) mediate significant myocardial improvement in a subset of advanced heart failure (HF) patients. The clinical and biological phenomena associated...
13.
Hanff T, Johnson M, Stehlik J
JACC Heart Fail
. 2024 Apr;
12(7):1284-1287.
PMID: 38613560
No abstract available.
14.
Lim H, Gonzalez-Costello J, Belohlavek J, Zweck E, Blumer V, Schrage B, et al.
J Heart Lung Transplant
. 2024 Mar;
43(7):1059-1073.
PMID: 38518863
Hemodynamic derangements are defining features of cardiogenic shock. Randomized clinical trials have examined the efficacy of various therapeutic interventions, from percutaneous coronary intervention to inotropes and mechanical circulatory support (MCS)....
15.
Taleb I, Kyriakopoulos C, Fong R, Ijaz N, Demertzis Z, Sideris K, et al.
JAMA Cardiol
. 2024 Jan;
9(3):272-282.
PMID: 38294795
Importance: The existing models predicting right ventricular failure (RVF) after durable left ventricular assist device (LVAD) support might be limited, partly due to lack of external validation, marginal predictive power,...
16.
Kanwar M, Billia F, Randhawa V, Cowger J, Barnett C, Chih S, et al.
J Heart Lung Transplant
. 2023 Dec;
43(2):189-203.
PMID: 38069920
In recent years, there have been significant advancements in the understanding, risk-stratification, and treatment of cardiogenic shock (CS). Despite improved pharmacologic and device-based therapies for CS, short-term mortality remains as...
17.
Baran D, Billia F, Randhawa V, Cowger J, Barnett C, Chih S, et al.
J Heart Lung Transplant
. 2023 Dec;
43(2):204-216.
PMID: 38069919
The last decade has brought tremendous interest in the problem of cardiogenic shock. However, the mortality rate of this syndrome approaches 50%, and other than prompt myocardial revascularization, there have...
18.
Dalia T, Pothuru S, Chan W, Mehta H, Goyal A, Farhoud H, et al.
Circ Heart Fail
. 2023 Jul;
16(8):e010462.
PMID: 37503601
Background: There is a paucity of data regarding epidemiology, temporal trends, and outcomes of patients with cardiogenic shock (CS) and end-stage renal disease (chronic kidney disease stage V on hemodialysis)....
19.
Alba A, Kirklin J, Cantor R, Deng L, Ross H, Jacobs J, et al.
J Heart Lung Transplant
. 2023 Jun;
42(11):1587-1596.
PMID: 37385418
Background: Limited data integrating waitlist and postheart transplant (HT) mortality have evaluated outcomes of left ventricular assist device (LVAD)-bridged strategy vs no LVAD according to patient characteristics. We evaluated waitlist...
20.
Zhang R, Hanff T, Zhang Y, Genuardi M, Peters C, Levin A, et al.
J Clin Med
. 2023 May;
12(10).
PMID: 37240595
Introduction: The contribution of chronotropic incompetence to reduced exercise tolerance after a heart transplant is well known, but its role as a prognostic marker of post-transplant mortality is unclear. The...